Nonetheless, recent studies have defined the roles of PTP1B and PTPN2 in the immune system and their potential as targets for cancer immunotherapy and somewhat paradoxically, this has sparked interest in the development of drugs capable of targeting both PTP1B and PTPN26,7,10,11,14,21. The gene discussed is PTPN1; the disease is cancer.